BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.97B |
| 2 |
Amazon
AMZN
|
+$430M |
| 3 |
Microsoft
MSFT
|
+$345M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$322M |
| 5 |
Health Care Select Sector SPDR Fund
XLV
|
+$302M |
Top Sells
| 1 |
SPDR S&P Biotech ETF
XBI
|
+$343M |
| 2 |
SPDR S&P 500 ETF Trust
SPY
|
+$308M |
| 3 |
Financial Select Sector SPDR Fund
XLF
|
+$301M |
| 4 |
IAC Inc
IAC
|
+$203M |
| 5 |
Visa
V
|
+$176M |
Sector Composition
| 1 | Technology | 17.42% |
| 2 | Consumer Discretionary | 10.68% |
| 3 | Healthcare | 7.66% |
| 4 | Financials | 7.63% |
| 5 | Communication Services | 7.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3126
First Western Financial
MYFW
$226M
| $15.7K | ﹤0.01% |
1,212
+978
| +418% | +$12.7K |
|
|
MBII
3127
DELISTED
Marrone Bio Innovations, Inc.
MBII
| $15.7K | ﹤0.01% |
12,845
+9,590
| +295% | +$11.7K |
|
3128
Mastech Digital
MHH
$90.5M
| $15.7K | ﹤0.01% |
870
+724
| +496% | +$13K |
|
3129
Evolution Petroleum
EPM
$179M
| $15.7K | ﹤0.01% |
6,989
+5,817
| +496% | +$13K |
|
3130
ProShares Ultra 7-10 Year Treasury
UST
$19.6M
| $15.6K | ﹤0.01% |
206
-372
| -64% | -$28.2K |
|
|
NH
3131
DELISTED
NantHealth, Inc
NH
| $15.6K | ﹤0.01% |
446
+378
| +556% | +$13.3K |
|
3132
OP Bancorp
OPBK
$217M
| $15.6K | ﹤0.01% |
2,733
+2,326
| +571% | +$13.3K |
|
3133
NextDecade
NEXT
$2.12B
| $15.2K | ﹤0.01% |
5,104
+2,760
| +118% | +$8.23K |
|
|
GFN
3134
DELISTED
General Finance Corporation
GFN
| $15.2K | ﹤0.01% |
2,394
+2,070
| +639% | +$13.1K |
|
3135
Landmark Bancorp
LARK
$154M
| $15K | ﹤0.01% |
897
+717
| +398% | +$12K |
|
3136
ARK Genomic Revolution ETF
ARKG
$1.01B
| $15K | ﹤0.01% |
+235
| New | +$15K |
|
|
TYME
3137
DELISTED
Tyme Technologies, Inc. Common Stock
TYME
| $14.8K | ﹤0.01% |
15,139
+10,905
| +258% | +$10.7K |
|
|
AXLA
3138
DELISTED
Axcella Health Inc. Common Stock
AXLA
| $14.8K | ﹤0.01% |
128
+116
| +967% | +$13.4K |
|
|
ATXI
3139
DELISTED
Avenue Therapeutics, Inc. Common Stock
ATXI
| $14.8K | ﹤0.01% |
+1
| New | +$14.8K |
|
3140
Arq
ARQ
$298M
| $14.8K | ﹤0.01% |
3,643
+2,808
| +336% | +$11.4K |
|
3141
Greene County Bancorp
GCBC
$384M
| $14.7K | ﹤0.01% |
1,358
+1,080
| +388% | +$11.7K |
|
|
PAMT
3142
PAMT CORP Common Stock
PAMT
$253M
| $14.7K | ﹤0.01% |
1,564
+1,296
| +484% | +$12.2K |
|
3143
Rimini Street
RMNI
$414M
| $14.6K | ﹤0.01% |
4,528
+2,954
| +188% | +$9.51K |
|
3144
Abeona Therapeutics
ABEO
$335M
| $14.6K | ﹤0.01% |
571
+478
| +514% | +$12.2K |
|
3145
Cibus
CBUS
$73M
| $14.5K | ﹤0.01% |
53
+32
| +152% | +$8.78K |
|
3146
Ponce Financial Group
PDLB
$334M
| $14.5K | ﹤0.01% |
2,291
+1,807
| +373% | +$11.4K |
|
3147
PAVmed
PAVM
$9.29M
| $14.4K | ﹤0.01% |
538
+448
| +498% | +$12K |
|
3148
Ericsson
ERIC
$26.5B
| $14.3K | ﹤0.01% |
1,315
-32,989
| -96% | -$359K |
|
3149
Mistras Group
MG
$301M
| $13.8K | ﹤0.01% |
3,535
+2,145
| +154% | +$8.39K |
|
3150
Lexicon Pharmaceuticals
LXRX
$392M
| $13.7K | ﹤0.01% |
9,527
+6,653
| +231% | +$9.58K |
|